XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2024
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Cost of goods sold

$

232

$

244

Selling, general and administrative

6,731

6,024

Research and development

126

154

Stock-based compensation expense

$

7,089

$

6,422

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2024

 

78,958

 

$

97.87

 

Granted

 

Exercised

 

(957)

69.64

Expired or forfeited

 

Outstanding at September 30, 2024

 

78,001

$

105.17

7.4 years

$

4,182

Exercisable at September 30, 2024

33,690

$

89.06

 

6.0 years

$

2,115

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2024

 

391,591

$

99.21

Granted

 

253,256

95.41

Vested

 

(297,418)

130.64

Forfeited

 

(2,400)

98.75

Nonvested at September 30, 2024

 

345,029

$

106.76